Communiqués de presse European Medicines Agency (EMA) — News Santé & sciences de la vie — Flux RSS et veille en direct
PPN World indexe les communiqués de presse de European Medicines Agency (EMA) — News et en archive chaque publication. Ce fil est silencieux depuis le 13 novembre 2026 — ses 70 communiqués indexés restent consultables, et une alerte vous préviendra dès qu'il publiera de nouveau.
Courriel quotidien gratuit
Ce qui tombe demain
Les grands événements mondiaux du lendemain, tirés de l’agenda PPN World (banques centrales, statistiques, élections, sommets), chaque soir à 17 h UTC.
Un courriel par jour. Aucun compte requis. Désabonnement en un clic.
À propos de ce fil
European Medicines Agency (EMA) — News fait partie des 1,400+ fils de presse que PPN World surveille en continu — un fil en anglais axé sur le secteur Santé & sciences de la vie, classé parmi nos fils internationaux. Chaque communiqué est dédupliqué, géolocalisé et enrichi d'un résumé IA, et vous pouvez y attacher des alertes sur recherches enregistrées. Le communiqué le plus récent de notre index a été publié le 13 novembre 2026; le fil est silencieux depuis.
Suivez European Medicines Agency (EMA) — News en temps réel dans PPN World
Chaque communiqué de European Medicines Agency (EMA) — News arrive dans le cockpit quelques secondes après sa publication — dédupliqué, classé, avec alertes sur recherches enregistrées et résumés IA, aux côtés de 1,400+ autres fils.
Créer un compte gratuit →Communiqués de European Medicines Agency (EMA) — News — archives
- Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 9-12 November 2026il y a 7 j
Seven new medicines recommended for approvalEMA’s human medicines committee (CHMP) recommended seven medicines for approval at its November 2026 meeting.The committee…, CHMP statistics Key figures fro…
- Meeting highlights from the Committee for Veterinary Medicinal Products (CVMP) 3-5 November 2026il y a 14 j
CVMP opinions on veterinary medicinal products Further to the re-examination of the opinion adopted by the Committee during its June 2026 meeting, the Committee adopted a…
- PRAC starts review of depression and anxiety medicine Deanxit (flupentixol/melitracen)il y a 21 j
EMA’s safety committee (PRAC) has started a review of Deanxit, a fixed-dose combination medicine for treating depression and anxiety, following reports of serious neurological…
- Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 26 - 29 October 2026il y a 21 j
PRAC starts review of depression and anxiety medicine Deanxit (flupentixol/melitracen)PRAC has started a review of Deanxit, a fixed-dose combination medicine for treating…, Agenda Agenda of the PRAC m…
- EMA closed on All Souls' Day, 2 Novemberil y a 22 j
EMA’s office is closed on Monday 2 November, to mark All Souls' Day. The office reopens at 08:30 on Tuesday 3 November.The product emergency hotline is available outside…
- AMA and EMA issue joint guidance on Ebola vaccine developmentil y a 28 j
EMA’s Emergency Task Force (ETF) and the African Medicines Agency (AMA) have published a joint position paper to support the timely start of clinical trials for potential…
- Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 12-15 October 2026il y a 35 j
Six new medicines recommended for approvalEMA’s human medicines committee (CHMP) recommended six medicines for approval at its October 2026 meeting.Rasonque (daraxonrasib)…, CHMP statistics Key figure…
- EMA recommends authorisation of Rasonque for metastatic pancreatic canceril y a 36 j
EMA’s human medicines committee (CHMP) has recommended granting a marketing authorisation in the European Union for Rasonque (daraxonrasib), an oral treatment for adults with…
- Meeting highlights from the Committee for Veterinary Medicinal Products (CVMP) 6-8 October 2026il y a 42 j
CVMP opinions on veterinary medicinal productsThe Committee adopted a positive opinion, in exceptional circumstances, for a marketing authorisation for Bovilis Lumpyvax (lumpy…
- Clinical trial applications advice pilot becomes permanentil y a 43 j
The Accelerating Clinical Trials in the EU (ACT EU) advice pilot, which helps sponsors prepare clinical trial applications, will become a permanent initiative from January 2027.…
- Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 28 September - 1 Octoberil y a 49 j
At its monthly meeting, EMA’s safety committee (PRAC) carried out its broad range of responsibilities to manage the safety of medicines, including the assessment of safety…, Agenda Agenda of the PRAC…
- Advice on ‘end-of-year’ submission dates for type I variations in 2026il y a 50 j
Marketing authorisation holders wishing to receive an outcome in 2026 should submit type IA annual updates, individual type IA and type IAIN variations, and super-groupings…
Les plus récents communiqués de ce fil défilent en direct pour les membres PPN World.
Questions fréquentes
Comment suivre les communiqués de European Medicines Agency (EMA) — News en temps réel?+
À quelle fréquence les communiqués de European Medicines Agency (EMA) — News sont-ils relevés?+
Quel type de communiqués European Medicines Agency (EMA) — News publie-t-il?+
Fils liés
- U.S. FDA
- UK Department of Health & Social Care
- NSW Minister for Health Media Releases
- U.S. CDC
- Inserm — Salle de presse
- Anses — Sécurité sanitaire (France)
- Ministério da Saúde (Brasil)
- Ministry of Health, Labour and Welfare Japan (MHLW)
- U.S. Department of Veterans Affairs (VA News)
- Statistics Canada — The Daily: Health